Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study.

ALLEGRA, L; KONIETZKO, N; LEOPHONTE, P; HOSIE, J; Pauwels, Romain; GUYEN, JN; PETITPRETZ, P

Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study.

L ALLEGRA, N KONIETZKO, P LEOPHONTE, J HOSIE, Romain Pauwels, JN GUYEN and P PETITPRETZ (1996) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY.

Mark

Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-188255

author

L ALLEGRA, N KONIETZKO, P LEOPHONTE, J HOSIE, Romain Pauwels, JN GUYEN and P PETITPRETZ

organization

Department of Internal medicine

year

1996

type

journalArticle (original)

publication status

published

subject

Medicine and Health Sciences

journal title

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

J. Antimicrob. Chemother.

issue

93-104 Suppl. A

Web of Science type

Article

ISSN

0305-7453

language

English

UGent publication?

yes

classification

id

188255

handle

http://hdl.handle.net/1854/LU-188255

date created

2004-01-14 13:41:00

date last changed

2016-12-19 15:37:58

@article{188255,
  author       = {ALLEGRA, L and KONIETZKO, N and LEOPHONTE, P and HOSIE, J and Pauwels, Romain and GUYEN, JN and PETITPRETZ, P},
  issn         = {0305-7453},
  journal      = {JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY},
  language     = {eng},
  number       = {93-104 Suppl. A},
  title        = {Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study.},
  year         = {1996},
}

Chicago: ALLEGRA, L, N KONIETZKO, P LEOPHONTE, J HOSIE, Romain Pauwels, JN GUYEN, and P PETITPRETZ. 1996. “Safety and Efficacy of Sparfloxacin in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Double-blind, Randomised, Parallel, Multicentre Study.” Journal of Antimicrobial Chemotherapy (93-104 Suppl. A).
APA: ALLEGRA, L., KONIETZKO, N., LEOPHONTE, P., HOSIE, J., Pauwels, R., GUYEN, J., & PETITPRETZ, P. (1996). Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (93-104 Suppl. A).
Vancouver: 1.
ALLEGRA L, KONIETZKO N, LEOPHONTE P, HOSIE J, Pauwels R, GUYEN J, et al. Safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1996;(93-104 Suppl. A).
MLA: ALLEGRA, L, N KONIETZKO, P LEOPHONTE, et al. “Safety and Efficacy of Sparfloxacin in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Double-blind, Randomised, Parallel, Multicentre Study.” JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 93-104 Suppl. A (1996): n. pag. Print.